Aquis Exchange Plc

Director's Dealing • Nov 25, 2021

National Storage Mechanism | Additional information

RNS Number : 5225T

Aquis Exchange PLC

25 November 2021

25 November 2021

Aquis Exchange PLC ("Aquis Exchange")

Director/PDMR Notification

Aquis Exchange PLC makes the following announcement regarding its Directors' participation in the Aquis Share Incentive Plan.

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Alasdair Haynes

2.

Reason for the notification

b)

Position / status

CEO

c)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Aquis Exchange PLC

b)

LEI

213800IXJSF5E1SIW150

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification Code

Ordinary Shares of 10p each 

GB00BD5JNK30

b)

Nature of the transaction

Alasdair Haynes participated in the Aquis Share Incentive Plan ("SIP"). The SIP is a HMRC approved tax-advantaged all-employee share scheme. Under it, employees are able to purchase ordinary shares at market value using deductions from salary, and receive allocations of matching and free ordinary shares. These ordinary shares are held by the employee benefit trust for the SIP.

c)

Price(s) and volume(s)

Price(s)	Volume(s)
655p	1,374

d)

Aggregated information

-     Aggregated volume

-      Price

1,374

655p

e)

Date of the transaction

23 November 2021

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Jonathan Clelland

2.

Reason for the notification

a)

Position / status

CFO & COO

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Aquis Exchange PLC

b)

LEI

213800IXJSF5E1SIW150

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification Code

Ordinary Shares of 10p each 

GB00BD5JNK30

b)

Nature of the transaction

Jonathan Clelland participated in the Aquis Share Incentive Plan ("SIP"). The SIP is a HMRC approved tax-advantaged all-employee share scheme. Under it, employees are able to purchase ordinary shares at market value using deductions from salary, and receive allocations of matching and free ordinary shares. These ordinary shares are held by the employee benefit trust for the SIP.

c)

Price(s) and volume(s)

Price(s)	Volume(s)
655p	1,374

d)

Aggregated information

-     Aggregated volume

-        Price

1,374

655p

e)

Date of the transaction

23 November 2021

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

Enquiries:

Aquis Exchange PLC	Tel: +44 (0) 7768 078 110
Belinda Keheyan, Head of Marketing
Liberum Capital Limited (Nominated Adviser and Joint Broker)	Tel: +44 (0) 20 3100 2000
Chris Clarke
Clayton Bush
Edward Thomas
Kane Collings
Canaccord Genuity Limited (Joint Broker)	Tel: +44 (0) 20 7523 8000
Bobbie Hilliam (Corporate Broking)
Alma PR (Financial PR Adviser)	Tel: +44 (0)20 3405 0209
Susie Hudson	aquis@almapr.co.uk
Kieran Breheny
Faye Calow

Notes to Editors

Aquis Exchange PLC is an exchange services group, which operates pan-European cash equities trading businesses (Aquis Exchange/AQX), growth and regulated primary markets (Aquis Stock Exchange/AQSE) and develops/licenses exchange software to third parties (Aquis Technologies).

Aquis Exchange (AQX) is authorised and regulated by the UK Financial Conduct Authority and France's Autorité des Marchés Financiers to operate Multilateral Trading Facility businesses in the UK/Switzerland and in EU27 respectively. AQX operates lit order books and does not allow aggressive non-client proprietary trading, which has resulted in lower market impact and signalling risk on AQX than other trading venues in Europe. According to independent studies, trades on Aquis are less likely to lead to price movement than on other lit markets. AQX uses a subscription pricing model which works by charging users according to the message traffic they generate, rather than a percentage of the value of each stock that they trade. 

Aquis Stock Exchange (AQSE) is a stock market providing primary and secondary markets for equity and debt products. It is authorised as a Recognised Investment Exchange, which allows it to operate a regulated listings venue. The AQSE Growth Market is divided into two segments 'Access' and 'Apex', with different levels of admission criteria. The Access market focuses on earlier stage growth companies, while Apex is the intended market for larger, more established businesses.

Aquis Technologies is the software and technology division of Aquis Exchange PLC. It creates and licenses cutting-edge, cost-effective matching engine and trade surveillance technology for banks, brokers, investment firms and exchanges.

Aquis Exchange PLC (AQX.L) is listed on the Alternative Investment Market of the LSE (AIM) market. For more information, please go to  www.aquis.eu

For more information, please go to www.aquis.eu and www.aquis.technology

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFFFLLLELSFIL